12:00 AM
Sep 29, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Medidur FA: Phase III ongoing

Alimera said for the second time a DSMB recommended continuation of a pair of double-blind, international Phase III trials (collectively know as the FAME Study) evaluating Iluvien (Medidur FA) for...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >